The Weekly Litigation News Digest is now live. Subscribe now

Biontech Rna Pharmaceuticals competitive analysis

Loading summary...

Explore patent oppositions filed by Biontech Rna Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Method For Producing Rna Molecule CompositionsCUREVACNov 12, 2020
Rna Containing Composition For Treatment Of Tumor DiseasesCUREVACMar 26, 2020

Explore Biontech Rna Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Oct 27, 2021Methods For Providing Single-Stranded Rna1
Sep 8, 2021Individualized Vaccines For Cancer1
Jul 10, 2019Individualized Vaccines For Cancer3

Latest PTAB cases involving Biontech Rna Pharmaceuticals

Discover the latest PTAB cases involving Biontech Rna Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Biontech Rna Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BIONTECH RNA PHARMACEUTICALS25 - -
CUREVAC - 62 - 1
IPRIME RENTSCH KAELIN1 - - -
WITHERS & ROGERS33 - - -